Healthcare Megarounds: 2022 activity dominated by Biotech.

66 healthcare funding rounds in excess of $100M, totalling $11.7B in ‘megarounds’ despite a rapidly cooling market

21 May 2022

US market and Biotech dominating 2022 activity. Investors backing firms focused on wellness and mental health with landmark deals for a number of players.

The healthcare market has seen 66 ‘megarounds’ (+$100M) so far this year, attracting $11.7B of investment capital. Biotech companies account for more than 45% of megarounds with private funding proving more accessible than bearish public markets.The US market is dominating geographically with 77% of all deals over $100M.

Outside of biotech, a focus on automation and cost reduction has seen investment flow into businesses that are utilizing the rapid improvement in machine learning and AI to help take cost out of healthcare systems. Data analytics organizations that can improve efficiency or better triage patients have attracted funding. Platform and software businesses that have proven they can remove administrative layers and improve functionality are also thriving. As we emerge from the pandemic investors are backing firms focused on wellness and mental health, with landmark deals for a number of players.

Customers can read the full analyst note on-platform. Not a customer yet? Request a demo of HolonIQ’s market intelligence platform.

Related Research

Global Health Funding 2022 – Half Year Update

1 July 2022.

Funding continues to flow in the first half of 2022 with $49.7B growth capital for health firms, despite a correction for digital and concerns around falling valuations.

The Complete List of Global Impact Unicorns

21 June 2022.

The Complete List of Global Impact Unicorns

Core values: Fitness market continues to innovate despite stock market correction

31 May 2022.

Share price woes mask underlying strong revenue growth for home fitness brands with subscription numbers outpacing pre-pandemic expectations.